Cetera Investment Advisers Has $603,000 Holdings in Walgreens Boots Alliance Inc (WBA)

Cetera Investment Advisers grew its position in Walgreens Boots Alliance Inc (NASDAQ:WBA) by 20.5% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 7,840 shares of the pharmacy operator’s stock after purchasing an additional 1,333 shares during the period. Cetera Investment Advisers’ holdings in Walgreens Boots Alliance were worth $603,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the business. Hudock Capital Group LLC raised its holdings in shares of Walgreens Boots Alliance by 0.5% during the second quarter. Hudock Capital Group LLC now owns 1,306 shares of the pharmacy operator’s stock worth $102,000 after acquiring an additional 6 shares during the period. Westside Investment Management Inc. raised its holdings in shares of Walgreens Boots Alliance by 10.4% during the second quarter. Westside Investment Management Inc. now owns 1,325 shares of the pharmacy operator’s stock worth $102,000 after acquiring an additional 125 shares during the period. Zions Bancorporation raised its holdings in shares of Walgreens Boots Alliance by 983.3% during the third quarter. Zions Bancorporation now owns 1,365 shares of the pharmacy operator’s stock worth $105,000 after acquiring an additional 1,239 shares during the period. IHT Wealth Management LLC raised its holdings in shares of Walgreens Boots Alliance by 46.3% during the second quarter. IHT Wealth Management LLC now owns 6,946 shares of the pharmacy operator’s stock worth $135,000 after acquiring an additional 2,199 shares during the period. Finally, Bristlecone Advisors LLC acquired a new stake in shares of Walgreens Boots Alliance during the third quarter worth $135,000. Institutional investors own 61.18% of the company’s stock.

In other news, Director John Anthony Lederer acquired 20,000 shares of the firm’s stock in a transaction dated Thursday, October 26th. The stock was bought at an average price of $67.00 per share, with a total value of $1,340,000.00. Following the transaction, the director now directly owns 50,000 shares in the company, valued at approximately $3,350,000. The purchase was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, Director William C. Foote sold 2,736 shares of Walgreens Boots Alliance stock in a transaction dated Thursday, November 2nd. The shares were sold at an average price of $67.37, for a total transaction of $184,324.32. Following the completion of the transaction, the director now directly owns 16,415 shares of the company’s stock, valued at approximately $1,105,878.55. The disclosure for this sale can be found here. 14.80% of the stock is currently owned by company insiders.

WBA has been the topic of a number of research analyst reports. Morgan Stanley lowered shares of Walgreens Boots Alliance from an “overweight” rating to an “equal weight” rating and dropped their price objective for the stock from $95.00 to $85.00 in a report on Friday, October 6th. BidaskClub upgraded shares of Walgreens Boots Alliance from a “strong sell” rating to a “sell” rating in a report on Friday, November 10th. Vetr upgraded shares of Walgreens Boots Alliance from a “buy” rating to a “strong-buy” rating in a report on Tuesday, December 12th. Robert W. Baird restated an “outperform” rating and set a $80.00 price objective (down from $90.00) on shares of Walgreens Boots Alliance in a report on Thursday, October 19th. They noted that the move was a valuation call. Finally, Citigroup dropped their price objective on shares of Walgreens Boots Alliance from $95.00 to $81.00 and set a “buy” rating on the stock in a report on Thursday, November 2nd. Nine research analysts have rated the stock with a hold rating, fifteen have given a buy rating and one has issued a strong buy rating to the stock. The stock presently has an average rating of “Buy” and a consensus price target of $86.20.

Walgreens Boots Alliance Inc (WBA) opened at $76.07 on Friday. The firm has a market cap of $75,340.00, a price-to-earnings ratio of 21.01, a P/E/G ratio of 1.28 and a beta of 1.22. Walgreens Boots Alliance Inc has a 12-month low of $63.82 and a 12-month high of $88.00. The company has a debt-to-equity ratio of 0.48, a current ratio of 0.96 and a quick ratio of 0.47.

Walgreens Boots Alliance (NASDAQ:WBA) last released its earnings results on Thursday, January 4th. The pharmacy operator reported $1.28 earnings per share for the quarter, beating analysts’ consensus estimates of $1.27 by $0.01. The business had revenue of $30.74 billion during the quarter, compared to the consensus estimate of $30.39 billion. Walgreens Boots Alliance had a net margin of 3.19% and a return on equity of 19.15%. The firm’s revenue for the quarter was up 7.9% compared to the same quarter last year. During the same quarter last year, the firm earned $1.10 earnings per share. equities analysts forecast that Walgreens Boots Alliance Inc will post 5.67 EPS for the current year.

Walgreens Boots Alliance declared that its Board of Directors has approved a share repurchase plan on Wednesday, October 25th that permits the company to repurchase $1.00 billion in shares. This repurchase authorization permits the pharmacy operator to buy shares of its stock through open market purchases. Shares repurchase plans are generally an indication that the company’s board of directors believes its stock is undervalued.

ILLEGAL ACTIVITY WARNING: This news story was originally posted by Community Financial News and is the sole property of of Community Financial News. If you are reading this news story on another publication, it was illegally stolen and republished in violation of international copyright & trademark legislation. The original version of this news story can be viewed at https://www.com-unik.info/2018/01/14/cetera-investment-advisers-has-603000-holdings-in-walgreens-boots-alliance-inc-wba.html.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit